Vitalhub (VHI) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
15 Jan, 2026Company overview and market position
Leading provider of healthcare software with over 1,300 customers and 600+ employees, operating globally since 2010.
Offers 50+ complementary solutions focused on optimizing healthcare outcomes and operational efficiency.
Achieved $90M+ in annual recurring revenue and maintains a 20%+ adjusted EBITDA margin.
Recognized for data privacy and security compliance (SOC 2, HIPAA, ISO).
Pursues a disciplined, self-sustained growth strategy with a coast-to-coast footprint in key markets.
Market opportunity and product portfolio
Targets a $10 billion software opportunity in single-payer healthcare regions including the UK, Canada, Australia, and the Middle East.
Portfolio spans patient flow, operational visibility, EHR, care coordination, workforce automation, and compliance.
Solutions address patient tracking, referrals, capacity planning, and workforce management.
Innovations Lab in Sri Lanka supports scalable, cost-effective R&D with 200+ technical staff.
Mergers & acquisitions strategy and history
Executes a synergistic consolidation strategy, centralizing functions and leveraging cross-selling.
Acquisitions target companies with $2–20M revenue, 60%+ recurring revenue, and 20%+ EBITDA margin.
Completed 23 acquisitions since inception, expanding product suite and geographic reach.
Maintains a global pipeline of 400+ targets, aiming for 5–7 year cash payback on deals.
Latest events from Vitalhub
- Q3 revenue and ARR up 25%, pro forma ARR hits CAD 68M after acquisitions, cash at CAD 81.4M.VHI
Q3 202411 May 2026 - ARR up 54% and revenue up 42%, with CAD 91.2M cash fueling strong M&A activity.VHI
Q1 202511 May 2026 - ARR and revenue surged year-over-year, margins improved, and cash reserves strengthened.VHI
Q1 202611 May 2026 - ARR and revenue surged in 2025, with robust EBITDA growth and strong cash for acquisitions.VHI
Q4 20254 May 2026 - Q2 revenue up 24% with 41% higher adjusted EBITDA and MedCurrent acquisition pending.VHI
Q2 20241 Feb 2026 - Growth through acquisitions and AI integration aims to boost recurring revenue and margins by 2026.VHI
2nd Annual Lytham Partners Healthcare Investor Summit15 Jan 2026 - Healthcare IT firm achieves $70M+ ARR via acquisitions, organic growth, and high-margin solutions.VHI
Planet MicroCap Showcase: VEGAS 202527 Dec 2025 - ARR up 59% and revenue up 31% in 2024, with robust M&A and strong cash position.VHI
Q4 202426 Dec 2025 - ARR up 55%, revenue up 47%, 26% EBITDA margin, and strong acquisition integration.VHI
Q2 202523 Nov 2025